Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,872.00
(
0.00%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.01
(
4.78%
)
Bitcoin
75,810.46
(
-0.11%
)
News Focus
News Focus
Post# of 257432
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 54
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: DewDiligence post# 52910

Thursday, 09/27/2007 11:35:02 AM

Thursday, September 27, 2007 11:35:02 AM

Post# of 257432
One down and one to go of the two that shorted their own stock.

I still find it funny that Vanda inlicensed iloperidone from Novartis and not Titan, yet Titan still lists it as a drug they are developing.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now